Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.47132 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.47225 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.49503 | 58 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.4617 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.42742 | 57 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.68775 | 60 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.49581 | 56 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.60719 | 60 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.43223 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.50866 | 59 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.50028 | 58 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.4239 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.3625 | 54 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.48934 | 58 |